With the quick swipe of a student ID and a plastic brown tray in hand, Megan Kono is left standing in the Dewick-MacPhie Dining Hall faced with a serious dilemma. As she moves from station to station, she must fight the ever-present temptation to grab a slice of fresh tomato pizza or dish out a serving of macaroni and cheese. She must walk quickly past the tub of French fries and the trays of cookies that Dewick offers on a daily basis.
As a swimmer Read the rest of this entry »

(NaturalNews) A luxuriously decadent cheesecake, a thick slab of marbled ham and a whipped cream-topped milkshake have something in common that might not be obvious. Sure, they are all loaded with fat. But new research concludes eating these and other high-fat foods can do more than add pounds. They may also seriously disrupt your internal biological “clock” that mimics the 24-hour cycle of the turning of the Earth. The result could be health problems Read the rest of this entry »

Dec. 23 (Bloomberg) –
is looking to widen
its share of the $94 billion market for biotechnology drugs by
developing generic versions of those therapies, following U.S.
rivals Merck & Co. and Eli Lilly & Co.
The London-based company is investigating the creation of
so-called biosimilars to expand in medicines made from living
cells, treatments that currently make up about 30 percent of its
pipeline. AstraZeneca’s facilities and technology may Read the rest of this entry »

Oct. 21, 2008 — Biological
, especially the pioneering ones, may have safety issues that come to light after the drugs’ approval.
That’s according to a new study, published in tomorrow’s edition of
.
In response to the study, a journal editorial points out that the FDA’s resources for checking drug safety “do not include a crystal ball,” and the pharmaceutical industry stresses the importance of reporting adverse reactions to any drug, whether Read the rest of this entry »

Oct. 21, 2008 — Biological
, especially the pioneering ones, may have safety issues that come to light after the drugs’ approval.
That’s according to a new study, published in tomorrow’s edition of
.
In response to the study, a journal editorial points out that the FDA’s resources for checking drug safety “do not include a crystal ball,” and the pharmaceutical industry stresses the importance of reporting adverse reactions to any drug, whether Read the rest of this entry »

A high-fat diet may lead people toward obesity because it can upset the body’s circadian rhythms, sometimes called the biological clock.
Researchers from the Hebrew University of Jerusalem studied an enzyme produced in the liver that increases fat burning and the body’s sensitivity to insulin.
The experimenters gave mice either a high-fat or low-fat diet, followed by a fasting day. They found that mice on the low-fat diet had a normal response Read the rest of this entry »

In the past few years, biological drugs, such as the MS treatment
, the arthritis drugs Humira and Remicade, and the cancer drugs Rituxan and Erbitux, have been plagued by safety worries.  According to a new report, a quarter of all biological drugs have been the subject of new safety warnings shortly after they were put on the market.
Biological drugs are defined as medicines whose active substance comes from a biological source.  The first Read the rest of this entry »